Silicone lubricants facilitate medical device functionality yet excessive levels cause problems - syringes with too much lubricant inject inconsistent doses, pharmaceutical containers shed particles, and biological drugs suffer protein aggregation from silicone interactions. Silicone oil quantification by FTIR following dichloromethane extraction provides specific detection of lubricant residues with characteriztic absorption at 1260 cm⁻¹ enabling selective quantification. Essential for syringes where silicone levels affect injection forces and dose accuracy, pharmaceutical containers where excessive silicone causes particle formation, and devices where silicone lubricants facilitate operation but must remain within controlled limits. The pooled sampling approach provides statistically representative results testing multiple units simultaneously while controlling analytical costs, enabling routine quality control without prohibitive expenses. For prefilled syringes and autoinjectors, silicone levels affect injection forces determining patient compliance and dose delivery accuracy through impact on plunger glide, dose accuracy where silicone variability causes inconsistent injection volumes, and biological drug stability where silicone induces protein aggregation compromising therapeutic efficacy. The FTIR methodology specifically detects polydimethylsiloxane lubricants through Si-O-Si stretching vibration, quantifies total silicone content regardless of molecular weight distribution, and accommodates various silicone types from light oils to heavy greases. Manufacturing validation establishes optimal silicone application levels balancing functional benefits against contamination concerns, confirms application processes achieve consistent coverage, and demonstrates levels remain stable during storage without migration or degradation. The testing supports investigation of functional problems including high injection forces or erratic plunger movement potentially caused by inadequate lubrication, particle contamination where excessive silicone sheds droplets, or biological drug instability linked to silicone-protein interactions.

Incoming materials arriving with certificates of analysis provide supplier claims yet independent verification prevents costly problems from wrong materials, contamination, or falsified documentation entering production. XRF screening provides rapid elemental analysis for RoHS compliance and material verification according to SR 817.023.21 requirements through non-destructive technique enabling 100% screening when required. This approach enables immediate material verification without sample preparation, prevents wrong materials from entering production through rapid pass/fail decisions, and detects contamination invisible to visual inspection including elemental impurities or coating defects. Essential for demonstrating compliance with hazardous substance restrictions limiting lead, cadmium, mercury, and hexavalent chromium, verifying supplier material certificates through independent testing preventing reliance on potentially inaccurate documentation, and investigating discoloration or corrosion issues potentially linked to elemental contamination or incorrect alloy composition. The non-destructive testing preserves materials for use after verification unlike destructive methods consuming samples, enables high-throughput screening processing numerous samples rapidly, and accommodates various sample forms from raw materials to finished components. For medical device manufacturing, XRF screening validates incoming stainless steel grades preventing costly production with wrong alloys, detects coating thickness variations ensuring consistent properties, and identifies elemental contamination sources during root cause investigations. The methodology provides semi-quantitative results adequate for screening with follow-up definitive testing when potential issues arise, reveals unexpected elements suggesting contamination or material substitution, and enables portable analysis testing materials at receiving or on production floor without laboratory delays.